Literature DB >> 33524065

Tripartite Motif 22 (TRIM22) protein restricts herpes simplex virus 1 by epigenetic silencing of viral immediate-early genes.

Tejaswini S Reddi1, Philipp E Merkl1, So-Yon Lim2, Norman L Letvin2, David M Knipe1.   

Abstract

Intrinsic resistance is a crucial line of defense against virus infections, and members of the Tripartite Ring Interaction Motif (TRIM) family of proteins are major players in this system, such as cytoplasmic TRIM5α or nuclear promyelocytic leukemia (PML/TRIM19) protein. Previous reports on the antiviral function of another TRIM protein, TRIM22, emphasized its innate immune role as a Type I and Type II interferon-stimulated gene against RNA viruses. This study shows that TRIM22 has an additional intrinsic role against DNA viruses. Here, we report that TRIM22 is a novel restriction factor of HSV-1 and limits ICP0-null virus replication by increasing histone occupancy and heterochromatin, thereby reducing immediate-early viral gene expression. The corresponding wild-type equivalent of the virus evades the TRIM22-specific restriction by a mechanism independent of ICP0-mediated degradation. We also demonstrate that TRIM22 inhibits other DNA viruses, including representative members of the β- and γ- herpesviruses. Allelic variants in TRIM22 showed different degrees of anti-herpesviral activity; thus, TRIM22 genetic variability may contribute to the varying susceptibility to HSV-1 infection in humans. Collectively, these results argue that TRIM22 is a novel restriction factor and expand the list of restriction factors functioning in the infected cell nucleus to counter DNA virus infection.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33524065      PMCID: PMC7877759          DOI: 10.1371/journal.ppat.1009281

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


  72 in total

1.  A first-generation packaging cell line for Epstein-Barr virus-derived vectors.

Authors:  H J Delecluse; D Pich; T Hilsendegen; C Baum; W Hammerschmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  Community engagement and informed consent in the International HapMap project.

Authors:  Charles Rotimi; Mark Leppert; Ichiro Matsuda; Changqing Zeng; Houcan Zhang; Clement Adebamowo; Ike Ajayi; Toyin Aniagwu; Missy Dixon; Yoshimitsu Fukushima; Darryl Macer; Patricia Marshall; Chibuzor Nkwodimmah; Andy Peiffer; Charmaine Royal; Eiko Suda; Hui Zhao; Vivian Ota Wang; Jean McEwen
Journal:  Community Genet       Date:  2007

3.  TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements.

Authors:  Anna Kajaste-Rudnitski; Sara S Marelli; Cinzia Pultrone; Thomas Pertel; Pradeep D Uchil; Nadir Mechti; Walther Mothes; Guido Poli; Jeremy Luban; Elisa Vicenzi
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

4.  Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein.

Authors:  Megan H Orzalli; Neal A DeLuca; David M Knipe
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-01       Impact factor: 11.205

5.  Associations between polymorphisms in the antiviral TRIM genes and measles vaccine immunity.

Authors:  Inna G Ovsyannikova; Iana H Haralambieva; Robert A Vierkant; Megan M O'Byrne; Gregory A Poland
Journal:  Hum Immunol       Date:  2013-02-13       Impact factor: 2.850

6.  The human IFN-inducible p53 target gene TRIM22 colocalizes with the centrosome independently of cell cycle phase.

Authors:  Jessica Petersson; Per Lönnbro; Anna-Maria Herr; Matthias Mörgelin; Urban Gullberg; Kristina Drott
Journal:  Exp Cell Res       Date:  2009-12-16       Impact factor: 3.905

7.  Interferon γ-inducible protein (IFI) 16 transcriptionally regulates type i interferons and other interferon-stimulated genes and controls the interferon response to both DNA and RNA viruses.

Authors:  Mikayla R Thompson; Shruti Sharma; Maninjay Atianand; Søren B Jensen; Susan Carpenter; David M Knipe; Katherine A Fitzgerald; Evelyn A Kurt-Jones
Journal:  J Biol Chem       Date:  2014-07-07       Impact factor: 5.157

8.  TRIM22 inhibits the TRAF6-stimulated NF-κB pathway by targeting TAB2 for degradation.

Authors:  Hui Qiu; Fang Huang; Han Xiao; Binlian Sun; Rongge Yang
Journal:  Virol Sin       Date:  2013-06-26       Impact factor: 4.327

9.  Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: involvement of host cellular factors.

Authors:  Yan Wang; Hong Li; Qiyi Tang; Gerd G Maul; Yan Yuan
Journal:  J Virol       Date:  2008-01-16       Impact factor: 5.103

10.  Quantitative temporal viromics: an approach to investigate host-pathogen interaction.

Authors:  Michael P Weekes; Peter Tomasec; Edward L Huttlin; Ceri A Fielding; David Nusinow; Richard J Stanton; Eddie C Y Wang; Rebecca Aicheler; Isa Murrell; Gavin W G Wilkinson; Paul J Lehner; Steven P Gygi
Journal:  Cell       Date:  2014-06-05       Impact factor: 41.582

View more
  6 in total

1.  Herpesvirus-mediated stabilization of ICP0 expression neutralizes restriction by TRIM23.

Authors:  Xing Liu; Dhiraj Acharya; Eric Krawczyk; Chase Kangas; Michaela U Gack; Bin He
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-21       Impact factor: 12.779

2.  Tissue-Resident-Memory CD8+ T Cells Bridge Innate Immune Responses in Neighboring Epithelial Cells to Control Human Genital Herpes.

Authors:  Tao Peng; Khamsone Phasouk; Catherine N Sodroski; Sijie Sun; Yon Hwangbo; Erik D Layton; Lei Jin; Alexis Klock; Kurt Diem; Amalia S Magaret; Lichen Jing; Kerry Laing; Alvason Li; Meei-Li Huang; Max Mertens; Christine Johnston; Keith R Jerome; David M Koelle; Anna Wald; David M Knipe; Lawrence Corey; Jia Zhu
Journal:  Front Immunol       Date:  2021-09-06       Impact factor: 8.786

3.  CHAF1A/B mediate silencing of unintegrated HIV-1 DNAs early in infection.

Authors:  Franziska K Geis; Yosef Sabo; Xiao Chen; Yinglu Li; Chao Lu; Stephen P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-25       Impact factor: 12.779

4.  Constitutive TRIM22 Expression in the Respiratory Tract Confers a Pre-Existing Defence Against Influenza A Virus Infection.

Authors:  Matthew Charman; Steven McFarlane; Joanna K Wojtus; Elizabeth Sloan; Rebecca Dewar; Gail Leeming; Mohammed Al-Saadi; Laura Hunter; Miles W Carroll; James P Stewart; Paul Digard; Edward Hutchinson; Chris Boutell
Journal:  Front Cell Infect Microbiol       Date:  2021-09-21       Impact factor: 5.293

Review 5.  Rational Design of Live-Attenuated Vaccines against Herpes Simplex Viruses.

Authors:  Brent A Stanfield; Konstantin G Kousoulas; Agustin Fernandez; Edward Gershburg
Journal:  Viruses       Date:  2021-08-18       Impact factor: 5.048

Review 6.  Local Immune Control of Latent Herpes Simplex Virus Type 1 in Ganglia of Mice and Man.

Authors:  Anthony J St Leger; David M Koelle; Paul R Kinchington; Georges Michel G M Verjans
Journal:  Front Immunol       Date:  2021-09-15       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.